HPCL Q1 Results: PAT skyrockets 93% QoQ to Rs 6204 croreADVERTISEMENTMankind Pharma Q1 Results: PAT soars 66% YoY to Rs 487 croreNifty breaks below 20-DMA. Nevertheless, it could provide an opportunity for some investors to take profits, leading to a possible pullback in the market. Foreign Institutional Investors (FIIs) have turned net sellers in the past few days, indicating a cautious stance in the market. This time the impact should be for a couple of days and the market may focus on other fundamental factors. We revise our TP to Rs 1,200 (vs. INR1,140 earlier), due to lower WACC assumptions, indicating a 9% upside potential.

Source: Economic Times August 02, 2023 15:31 UTC